Imidazole derivatives as cholesterol-lowering agents
- 31 August 2003
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 90 (2-3) , 145-146
- https://doi.org/10.1016/s0167-5273(02)00561-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Novel approaches to lipid lowering: what is on the horizon?The American Journal of Cardiology, 2001
- Effects of 2-(substituted-sulfanyl)-3,5-dihydro-imidazole-4-one and 2-(substituted-sulfanyl)-1H-imidazole-4,5-dione derivatives on serum HDL-cholesterolBioorganic & Medicinal Chemistry Letters, 2000
- Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretionClinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- Effects of ketoconazole on plasma lipids and lipoprotein(a) in familial hypercholesterolaemia, compared with simvastatin.The Netherlands Journal of Medicine, 1997
- Acyl-CoA:CholesterolO-Acyltransferase (ACAT) Inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as Potent Inhibitors of ACATJournal of Medicinal Chemistry, 1996
- Program on the Surgical Control of the HyperlipidemiasJournal of Cardiovascular Pharmacology, 1995
- Effect of ketoconazole on cholesterol synthesis and on HMG-COA reductase and LDL-receptor activities in Hep G2 cellsBiochemical Pharmacology, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984